Company Filing History:
Years Active: 2021-2025
Title: Inventor Spotlight: Daniel Anthony Briere
Introduction
Daniel Anthony Briere, an accomplished inventor, resides in Morgantown, Indiana, and is notable for his contributions to the field of medicine and pharmaceutical compositions. With a total of four patents to his name, Briere has focused his research on innovative solutions for treating obesity and diabetes, significantly impacting the healthcare landscape.
Latest Patents
Briere's latest patents include groundbreaking work on protein tyrosine-tyrosine analogs and long-acting amylin receptor agonists. The first patent describes PYY analogs that feature modifications to enhance half-life compared to human PYY, while also improving potency and selectivity for the NPY2 receptor. These advancements promise pharmaceutical compositions aimed at treating obesity and associated diseases, such as type II diabetes mellitus. The second patent focuses on compounds that stimulate the amylin receptor, helping to lower food intake, body weight, glucose levels, and triglycerides, thereby facilitating the treatment of diabetes, obesity, and dyslipidemia.
Career Highlights
Briere currently works at Eli Lilly and Company, a renowned pharmaceutical corporation known for its commitment to improving global health through innovative medicines. His work has not only garnered him patents but also positioned him as a significant contributor to the ongoing dialogue around effective treatments for persistent health issues.
Collaborations
Throughout his career, Briere has collaborated with talented colleagues, including Daniel Christopher Lopes and Avinash Muppidi. These partnerships have fostered a creative environment, encouraging groundbreaking research and development within the pharmaceutical sector.
Conclusion
Daniel Anthony Briere exemplifies the impact that dedicated inventors can have on healthcare through their innovations. His work at Eli Lilly and Company and his patented inventions underscore the importance of continued research into treatments for obesity and diabetes, thereby improving the quality of life for individuals affected by these conditions.